期刊文献+

焦磷酸测序分析ABCG2基因多态性方法的建立 被引量:4

Development of pyrosequencing method for detection of ABCG2 polymorphisms
下载PDF
导出
摘要 目的:建立ABCG2 34G>A和421C>A单核苷酸多态性位点的焦磷酸测序方法。方法:抽取志愿者静脉血入EDTA抗凝管,常规苯酚/氯仿法制备全血gDNA,生物素标记引物对扩增多态位点目的片段,制备生物素标记单链模板,与测序引物退火结合后行焦磷酸测序。分析结果经毛细管电泳测序验证,并进行重复性检验。结果:本文建立了针对ABCG2 34G>A和421C>A多态性位点的焦磷酸测序方法,经毛细管电泳测序验证和重复性验证,结果准确可靠。ABCG2 34G和34A等位基因频率分别为79.5%和20.5%;421C和421A等位基因频率分别为72.7%和27.8%,均符合Hardy-Weinberg平衡。结论:本文建立的焦磷酸测序方法可准确、高通量、快速检测ABCG2 34G>A和421C>A单核苷酸多态性,并且特别适宜大样本量的临床及科研批量检测需要。 AIM: To establish a pyrosequenc- ing based method for detection ABCG2 34G〉A and 421C〉A polymorphisms and to determine the frequency of these polymorphisms in healthy Chinese. METHODS: After preparation of gD- NA from blood of 200 subjects, the target frag- ments were amplified by PCR, polymorphisms were detected on PyroMark ID by pyrosequenc- ing technology. The reliability of pyrosequenc- ing methods were validated by repeat tests and Sanger sequencing. RESULTS: We established a new pyrosequencing method to detect the AB- CG2 34G〉A and 421C〉A polymorphisms poly- morphisms in healthy Chinese. The detection rate and repetition rate were both 100%. The frequencies of ABCG2 34G and 34A alleles were 79.5% and 20.5 % respectively. The allele fre- quencies of ABCG2 421C and 421A were 72.7%and 27.8%, respectively. Genotype frequencies match the Hardy-Weinberg equilibrium. CON- CLUSION: These pyrosequencing assays to de- tect ABCG2 polymorphisms are proved to be a rapid, accurate and high-throughput alternative to conventional methods, and it can be a pre- ferred option in research and clinical application.
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第7期779-784,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(81072706 81173134) 高等学校博士学科点专项科研基金资助课题(20090162120024) 湖南省科技计划项目(2009JT3020) 中央高校基本科研业务费(2012QNZT085 2012QNZT133)
关键词 药理学 焦磷酸测序 ABCG2 乳腺癌耐药蛋白 单核苷酸多态性 Pharmacology Pyrosequencing ABCG2 BCRP SNPs
  • 相关文献

参考文献23

二级参考文献69

  • 1倪红兵,鞠少卿,王惠民.焦磷酸测序技术及其应用进展[J].国外医学(临床生物化学与检验学分册),2005,26(9):600-602. 被引量:9
  • 2Zhao F, Loke C, Rankin SC, et al. Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose[J]. Clin Pharmacol Ther, 2004, 76(3) :210- 219. 被引量:1
  • 3Ruilin C, Lin SM, Ye F, et al. Methylation status of the interferon-gamma gene promoter in chronic hepatitis B [J]. ACAD J XJ TU, 2008,20(3) :206 - 212. 被引量:1
  • 4Faas SJ, Menon R, Braun ER, et al. Sequence-specific priming and exonuclease-released fluorescence detection of HLA-DQB1 alleles[J]. Tissue Antigens, 1996,48(2) :97 - 112. 被引量:1
  • 5Agundez JA. Cytochrome P450 gene polymorphism and cancer[J]. Curr Drug netab, 2004,5(3):211 -224. 被引量:1
  • 6Takanashi K, Tainaka H, Kobayashi K, et al. CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates[ J]. Pharmacogenetics, 2000, 10(2) : 95 - 104. 被引量:1
  • 7Dupont JM, Tost J, Jammes H, et al. De novo quantitative bisulfite sequencing using the Pyrosequencing technology[J]. Anal Biochem, 2004,333(1): 119- 127. 被引量:1
  • 8Damaraju S, Murray D, Dufour J, et al. Association of DNA repair and steroid metabolism gene polymorphis- mswith clinical late toxicity in patients treated with conforreal radiotherapy for prostate cancer[ J]. Clin Cancer Res, 2006, 12(8) :2545 - 2554. 被引量:1
  • 9Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by PyrosequencingTM[ J]. Biotechniques, 2003,35 ( 1 ) : 152 - 156. 被引量:1
  • 10Shendure J, Mitra RD, Varma C, et al. Advanced sequencing technologies: methods and goals [ J ]. Nat Rev Genet, 2004,5(5) :335 - 344. 被引量:1

共引文献21

同被引文献47

  • 1李方,叶启东,唐跃年,张顺国.高效液相色谱法测定人血红细胞内硫鸟嘌呤核苷酸浓度[J].中国药房,2006,17(6):438-440. 被引量:3
  • 2马晓莉,吴敏媛,胡亚美,朱平,李志刚.巯嘌呤甲基转移酶基因多态性位点与酶活性的关系[J].中华肿瘤杂志,2006,28(6):456-459. 被引量:10
  • 3熊晖,熊磊,苏丹,辛华雯,吴笑春,李罄,李高.HPLC法检测人红细胞中巯嘌呤甲基转移酶的活性[J].中国药师,2007,10(8):738-740. 被引量:4
  • 4Kobayashi D, Ieiri I, Hirota T, et al. Functional assessment of ABCG2 (BCRP) gene polymor- phisms to protein expression in human placenta [J]. Drug Metab Dispos,2005, 33(1): 94-101. 被引量:1
  • 5Backstrom G, Taipalensuu J, Melhus H, et al. Ge- netic variation in the ATP-binding cassette trans- porter gene ABCG2 (BCRP) in a Swedish popula- tion [J]. Eur J Pharm Sci,2003, 18(5) : 359-364. 被引量:1
  • 6Iida A, Saito S, Sekine A, et al. Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette trans- porters: ABCA4, ABCA7, ABCAS, ABCDI, AB- CD3, ABCD4, ABCE1, ABCF1, ABCG1, AB- CG2, ABCG4, ABCGS, and ABCG8 [J]. J HumGenet, 2002, 47(6): 285-310. 被引量:1
  • 7Zamber CP, Lamba JK, Yasuda K, et al. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine [J]. Pharmacogenetics, 2003, 13(1) :19-28. 被引量:1
  • 8Mizuarai S, Aozasa N, Kotani H. Single nucleotide polymorphisms result in impaired membrane locali- zation and reduced atpase activity in multidrug transporter ABCG2 [J]. Int J Cancer, 2004, 109 (2): 238-246. 被引量:1
  • 9Huang, MM, Arnheim N, Goodman MF. Exten- sion of base mispairs by Taq DNA polymerase: im- plications for single nucleotide discrimination in PCR[J]. Nucleic Acids Res,1992, 20(17): 4567- 4573. 被引量:1
  • 10Newton CR, Graham A, Heptinstall LE, et al. A- nalysis of any point mutation in DNA. The amplifi- cation refractory mutation system (ARMS) [J].Nucleic Acids Res,1989, 17(7) : 2503-2516. 被引量:1

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部